Zumutor Biologics

Zumutor Biologics is a clinical-stage biotechnology startup focused on developing novel immunotherapy drugs that harness and activate the body’s innate immune system, particularly natural killer (NK) cells, to treat solid tumours. The company develops antibody engineering platforms and targeted biologics designed to modulate the tumour microenvironment, enable combination regimens with other cancer therapies, and advance candidates through preclinical and clinical development with an emphasis on translational research, biomarker-driven studies, and global clinical trial execution.